Skip to main content
    A

    Alterity Therapeutics Ltd (ATHE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.89
    -0.07 (-3.57%)

    Market Cap: $37.42M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Alterity Therapeutics Ltd (ATHE) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Alterity Therapeutics (ATHE) has a latest price of $1.89 on Nov 17, 2026, 67.9% below its 52-week high of $5.89. Its price fell 50.8% over the past 12 months. The month-end price fell 92.7% over the 10 years through Oct 2026, a compound annual decline of 23.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $32.70 in Nov 2017 and its lowest $1.15 in Oct 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ATHE with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ATHE.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 60.6%, and over 6 months it fell 55.7%. The month-end price fell 7.4% over the 3 years through Oct 2026, a compound annual decline of 2.5%.

    PeriodChange
    1 month-22.2%
    3 months-60.6%
    6 months-55.7%
    12 months-50.8%
    12 months, with dividends-50.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-7.4%-2.5%
    5 years-82.3%-29.3%
    10 years-92.7%-23.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 91.4%, and its weakest was 2018, when it fell 59.0%.

    YearCloseChange
    2026 through Oct 2026$2.16-29.9%
    2025$3.08-6.9%
    2024$3.31+32.9%
    2023$2.49-28.5%
    2022$3.48-51.6%
    2021$7.20-46.3%
    2020$13.40+71.8%
    2019$7.80-39.1%
    2018$12.80-59.0%
    2017$31.20+91.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 35.6% below its 50-day average of $2.93 and 51.7% below its 200-day average of $3.91.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.89
    52-week high$5.89-67.9%
    52-week low$1.70+11.2%
    50-day average$2.93-35.6%
    200-day average$3.91-51.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 75.0%.

    MeasureValue
    1-year beta1.20
    Largest fall, 1 year-67.9%
    Largest fall, 3 years-75.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ATHE

    What is ATHE's 1-year price change?

    Alterity Therapeutics's price fell 50.8% over the past 12 months. With dividends included, the 12-month total return was -50.8%.

    What is ATHE's 5-year price change?

    Alterity Therapeutics's month-end price fell 82.3% over the 5 years through Oct 2026, a compound annual decline of 29.3%. These figures leave out dividends.

    What is ATHE's 52-week high and low?

    Alterity Therapeutics's 52-week high is $5.89 and its 52-week low is $1.70. Its latest price of $1.89 on Nov 17, 2026 is 67.9% below the high.

    What is ATHE's beta?

    Alterity Therapeutics's 1-year beta against the S&P 500 is 1.20, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 67.9%.

    Is the ATHE chart free?

    Yes. Advanced Charting for ATHE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.